With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.165253-29-2,3-(Bromomethyl)tetrahydrofuran,as a common compound, the synthetic route is as follows.
A solution of 3-(bromomethyl)tetrahydrofuran (8.OOg, 48.48 mmol) and 2-amino pyridine (9.12g,97.02 mmol) in sulfolane (250 mL) was heated to 80 00 for 70 hours. The reaction was thencooled to room temperature and then diluted with 5 L of CH2CI2, and twice extracted with 500 mL of water. The aqueous phase was concentrated in vacuo. To the residue was then added CH2CI2 (100 mL) and a thick orange oil precipitated. The CH2CI2 was decanted and the oil dried in vacuo to afford the desired salt as a wax contaminated with a trace amount of sulfolane (1 .1 g,9percent yield).LC-MS: mass calc?d. for 010H15N20 [M] 179.1, found 179.3; RT = 0.326 mm.
165253-29-2, 165253-29-2 3-(Bromomethyl)tetrahydrofuran 14173422, aTetrahydrofurans compound, is more and more widely used in various fields.
Reference£º
Patent; BASF SE; BANDUR, Nina Gertrud; MCLAUGHLIN, Martin John; POHLMAN, Matthias; DIETZ, Jochen; VON DEYN, Wolfgang; WO2015/28630; (2015); A1;,
Tetrahydrofuran – Wikipedia
Tetrahydrofuran | (CH2)3CH2O – PubChem